Month: October 2018

BUHLMANN fCAL ELISA Promotion

An FDA-Cleared Gastrointestinal Test to Distinguish IBD from IBS Calprotectin is a highly-sensitive clinical biomarker shown to be extremely useful as an aid in diagnosis of inflammatory diseases in the gastrointestinal tract. The BÜHLMANN fCAL® ELISA is an in vitro diagnostic assay intended for the quantitative measurement of fecal calprotectin in human stool. The BÜHLMANN fCAL®  ELISA aids
Continue Reading

IBDoc® Talk – Tips and Tricks Teleconference

Health Canada Licence: 98903, Device class: 3  BÜHLMANN IBDoc® is not available for sale in the US. IBDoc® is the first self-testing application for fecal calprotectin in IBD patients that involves three easy steps. IBDoc® allows IBD patients convenient self-testing of fecal calprotectin. Teleconference Overview Goal of Discussion The goal was for Clinical Administrators and Clinical Users from
Continue Reading

BUHLMANN Quantum Blue® fCAL Tutorial

View this demonstration of CALEX® Cap extraction and quantitative fecal calprotectin measurement using the Quantum Blue® fCAL rapid test technology. Quantum Blue® fCAL high range:  Health Canada License: 88674 Quantum Blue® fCAL: Health Canada License: 83477 US: (The Quantum Blue® tests are for Research Use Only. Not for use in diagnostic procedures in the US.) Contact BUHLMANN Today! Contact
Continue Reading